查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1780711

全球药物涂层球囊导管市场

Drug-Coated Balloon Catheters
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 375 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球药物涂层球囊导管市场规模将达21亿美元

全球药物涂层球囊导管市场规模预计在2024年为15亿美元，预计到2030年将达到21亿美元，在分析期内（2024-2030年）的复合年增长率为6.0%。紫杉醇是本报告分析的细分市场之一，预计其复合年增长率为4.9%，到分析期末达到13亿美元。Sirolimus细分市场在分析期间的复合年增长率预计为8.0%。

美国市场规模估计为 3.958 亿美元，中国市场预计复合年增长率为 9.2%

美国药物涂层球囊导管市场规模预计2024年达到3.958亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到4.149亿美元，在分析期间（2024-2030年）的复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.0%和5.8%。在欧洲，预计德国市场的复合年增长率为3.9%。

全球药物涂层球囊导管市场－主要趋势与驱动因素摘要

药物涂层球囊导管为何在心血管治疗中受到关注？

药物涂层球囊 (DCB) 导管已成为介入性心臟病学和血管外科领域的颠覆性技术。与传统支架不同，DCB 将抗增生药物直接输送至血管壁，降低血管再阻塞风险，且不会留下永久性植入。这些装置尤其适用于治疗冠状动脉疾病、周边动脉疾病(PAD) 和支架内血管再阻塞，为患者提供更安全、併发症更少的选择。

哪些技术进步正在提升 DCB 的效能？

无聚合物药物涂层、亲水性递送系统和生物分解性载体的突破性进展，提高了药物在目标动脉中的滞留和吸收。紫杉醇和Sirolimus涂层DCB的开发，使治疗效果更持久，副作用更小。导管灵活性、精准药物递送和影像引导部署方面的进步，进一步改善了手术效果。

法规和市场需求如何影响采用？

美国食品药物管理局 (FDA) 和 CE 认证机构等监管机构越来越多地核准DCB 用于介入心臟病学以外的新适应症，扩大了其在治疗糖尿病血管併发症和动静脉瘻管方面的应用。此外，微创手术和门诊手术的兴起也推动了 DCB 的需求，使其成为一种经济高效的药物释放型支架 (DES) 替代品。

推动市场成长的因素是什么？

药物涂层球囊导管市场的成长动力源自于心血管疾病盛行率的上升、无支架治疗的偏好普及以及药物输送涂层技术的进步。人口老化、门诊血管成形术的普及以及新药製剂临床试验的持续进行也推动了市场的发展。此外，DCB 应用领域向非心血管治疗领域的扩展也拓展了其临床应用价值和商业性潜力。

部分

类型（紫杉醇、Sirolimus）；产品（冠状动脉疾病、週边血管疾病）；最终使用者（医院、诊所、门诊手术中心）

受访公司范例

  • Abbott Laboratories
  • Alvimedica
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BD（Becton, Dickinson and Company）
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular SLU
  • Koninklijke Philips NV
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • OrbusNeich Medical Group
  • QT Vascular Ltd.
  • Shockwave Medical, Inc.
  • Surmodics, Inc.
  • Terumo Corporation
  • TriReme Medical, LLC

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP30608

Global Drug-Coated Balloon Catheters Market to Reach US$2.1 Billion by 2030

The global market for Drug-Coated Balloon Catheters estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Paclitaxel, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Sirolimus segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$395.8 Million While China is Forecast to Grow at 9.2% CAGR

The Drug-Coated Balloon Catheters market in the U.S. is estimated at US$395.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$414.9 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global "Drug-Coated Balloon Catheter" Market - Key Trends & Drivers Summarized

Why Are Drug-Coated Balloon Catheters Gaining Traction in Cardiovascular Care?

Drug-coated balloon (DCB) catheters have become a game-changer in interventional cardiology and vascular surgery. Unlike traditional stents, DCBs deliver antiproliferative drugs directly to vessel walls, reducing the risk of restenosis without leaving a permanent implant. These devices are particularly useful for coronary artery disease, peripheral artery disease (PAD), and in-stent restenosis, offering a safer alternative with fewer complications.

What Technological Advances Are Improving DCB Performance?

Breakthroughs in polymer-free drug coatings, hydrophilic delivery systems, and biodegradable carriers have enhanced drug retention and absorption in target arteries. The development of paclitaxel-based and sirolimus-coated DCBs has led to longer-lasting therapeutic effects with minimal side effects. Advances in catheter flexibility, precision drug dosing, and imaging-guided deployment have further improved procedural outcomes.

How Are Regulations and Market Demand Influencing Adoption?

Regulatory bodies like the FDA and CE Marking agencies are increasingly approving DCBs for new indications beyond cardiovascular interventions, expanding their use in diabetic vascular complications and arteriovenous fistula treatments. The rise in minimally invasive surgeries and outpatient procedures has also driven demand for DCBs as a cost-effective and efficient alternative to drug-eluting stents (DES).

What Is Propelling the Market Growth?

The growth in the Drug-Coated Balloon Catheter market is fueled by the rising prevalence of cardiovascular diseases, increasing preference for non-stent-based interventions, and advancements in drug delivery coatings. The aging population, growing adoption of outpatient angioplasty procedures, and ongoing clinical trials for new drug formulations are also key market drivers. Furthermore, the expansion of DCB applications into non-cardiac vascular treatments is broadening their clinical relevance and commercial potential.

SCOPE OF STUDY:

The report analyzes the Drug-Coated Balloon Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Paclitaxel, Sirolimus); Product (Coronary Artery Disease, Peripheral Vascular Disease); End-Use (Hospital, Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BD (Becton, Dickinson and Company)
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Eurocor GmbH
  • iVascular S.L.U.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • OrbusNeich Medical Group
  • QT Vascular Ltd.
  • Shockwave Medical, Inc.
  • Surmodics, Inc.
  • Terumo Corporation
  • TriReme Medical, LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Drug-Coated Balloon Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Peripheral Artery Disease Propels Growth of Drug-Coated Balloon Catheters Market
    • Rising Geriatric Population Base Strengthens Business Case for Minimally Invasive Vascular Interventions
    • Shift Toward Endovascular Therapies Spurs Demand for Advanced Drug-Coated Balloon Technologies
    • Favorable Clinical Outcomes in Real-World Studies Drives Adoption Among Interventional Cardiologists
    • Increasing Healthcare Investments in Emerging Markets Expands Addressable Market Opportunity
    • Surge in Cardiovascular Disease Burden Across Asia-Pacific Accelerates Demand for Drug-Eluting Devices
    • Reimbursement Advancements in Europe and the U.S. Strengthen Market Accessibility and Uptake
    • Growing Focus on Limb Salvage in Critical Limb Ischemia Patients Drives Utilization of DCBs
    • Technological Innovations in Coating Materials and Drug Delivery Mechanisms Propel Product Differentiation
    • Regulatory Approvals and Fast-Track Designations in Key Markets Drive Commercial Launch Momentum
    • Increasing Clinical Trials and Data Transparency Strengthen Physician Confidence and Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug-Coated Balloon Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug-Coated Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Paclitaxel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Paclitaxel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Paclitaxel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sirolimus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sirolimus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sirolimus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Peripheral Vascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Peripheral Vascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Peripheral Vascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Drug-Coated Balloon Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Drug-Coated Balloon Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Drug-Coated Balloon Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Drug-Coated Balloon Catheters by Type - Paclitaxel and Sirolimus Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by Type - Percentage Breakdown of Value Sales for Paclitaxel and Sirolimus for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Drug-Coated Balloon Catheters by Product - Coronary Artery Disease and Peripheral Vascular Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by Product - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Vascular Disease for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Drug-Coated Balloon Catheters by End-Use - Hospital, Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Drug-Coated Balloon Catheters by End-Use - Percentage Breakdown of Value Sales for Hospital, Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION